Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies
Military Medical Academy of S.M. Kirov, Saint-Petersburg, Russia Recent clinical trials about the cardiovascular safety of empagliflozin and liraglutide demonstrated a convincing lowering effect on mortality from cardiovascular causes among the patients with type 2 diabetes. These findings resulted...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0938f70fe352468e937a00e32e7e3b3e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|